Chamberlain Healthcare PR appoints Mark Cater
pharmafile | January 20, 2010 | Appointment | Medical Communications | Chamberlain Healthcare PR, appointment, medical communications
Mark Cater has been appointed managing director of Chamberlain Healthcare PR’s London office.
Prior to joining Chamberlain, Cater was regional director, Europe, Middle East, Africa & India for Cohn & Wolfe, and chief executive officer of GCI U.K. prior to the company merging in 2008 with Cohn & Wolfe.
Mark previously spent six years in various leadership roles as partner and director at public relations agency Ketchum where he was responsible for the company’s worldwide healthcare practice and served in both the London and New York offices.
In his new role, Cater will also become a member of the agency management team working with Chamberlain’s senior leaders including managing director and global practice head Jonathan Wilson, with whom he previously worked in both London and New York, as well as managing partner Deborah Cohen, and executive vice presidents Jennifer O’Neill and Reba Auslander.
Operating in London since 2008, Chamberlain has built a small but significant presence working on behalf of several of its US-based worldwide pharmaceutical clients on their global brands and issues.
“Given our brief tenure but serious intentions in London, it is important we attract the best leadership,” said Richard Chamberlain, president of Chamberlain Healthcare Public Relations. “Mark’s twenty-two years of public relations experience in both the public and private sectors across the UK, European & US markets makes him exceptionally qualified to lead our London team, support our worldwide clients and further our global communications efforts.”
Related Content
Men’s health – a new report from the Department of Health and Social Care
The UK Department of Health and Social Care has published a new report entitled Men’s …
PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …
David Wheadon appointed to board of directors at Seaport Therapeutics
This week, Seaport Therapeutics have appointed David Wheadon MD to their board of directors.
